Exodus Point Capital Management, LP Oramed Pharmaceuticals Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$3.72 - $9.0 $68,169 - $164,925	-18,325 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.19 - $13.89 $150,081 - $254,534	18,325 New	18,325 $159,000
Q2 2021 Aug 16, 2021	SELL	$8.34 - $14.59 $437,733 - $765,770	-52,486 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.22 - $11.33 $221,490 - $594,666	52,486 New	52,486 $533,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.